Prophylaxis with Direct-acting Antivirals for Kidney Transplantation from Hepatitis C Virus-Infected Donors to Uninfected Recipients: a Randomized Controlled Trial

Brief description of study

The purpose of this research study is to learn about the best approach to treat Hepatitis C Virus (HCV) in kidney transplant recipients.

Clinical Study Identifier: s24-00733

ClinicalTrials.gov Identifier: NCT05653232

Principal Investigator: Aprajita Mattoo.

Other Investigators: Kathryn Sterling Dzurilla, Robert Montgomery, Vasishta Tatapudi, Bruce E Gelb, Elaina Weldon, Nicole M Ali, Jonathan C Berger, Irfana Soomro, Jeffrey Marc Stern, Rebecca Anne Esker, Ryan Patrick Robalino, Joseph Chung Lee, Pablo Loarte-Campos.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies